1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62EC7E7C5ACE0E62B002585DF00458E90
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/2EC7E7C5ACE0E62B002585DF00458E90?OpenDocument
18
19OpenDocument
2044.201.72.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Patient Focused Services Patient Advocacy Groups

Document Excerpt: Patient Support Excellence: Critical Programs, Tactics & Tools to Ensure Strong Advocacy & Access to Medicine during COVID-19 and Beyond

DB Image

Excerpt in Cart

ID: MD-736


Features:

6 Info Graphics

15 Data Graphics

260+ Metrics

7 Narratives


Pages/Slides: 5


Published: 2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5636 "Patient Support Excellence: Critical Programs, Tactics & Tools to Ensure Strong Advocacy & Access to Medicine during COVID-19 and Beyond”.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Health Care; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Agios; Alnylam Pharmaceuticals; AstraZeneca; Boehringer Ingelheim; CSL Behring; Daiichi Sankyo; Genmab; Ironwood; Merck KGaA; Milestone Pharmaceuticals; MSD; Nestle Health Science; Novartis; OTSUKA; Pfizer; Retrophin; Sanofi; Takeda Pharmaceuticals; Theravance

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.